Skip to main content
JW LIFESCIENCE CORPORATION logo

JW LIFESCIENCE CORPORATION - Investor Relations & Filings

Listed IPO Oct 2016
Ticker · 234080 ISIN · KR7234080000 KO Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2026-02-10 Notice of Dividend Amou…
Country KR South Korea
Listing KO 234080 · 1 venue

About JW LIFESCIENCE CORPORATION

https://www.jw-lifescience.co.kr/lifesc…

JW LIFESCIENCE CORPORATION is a specialized manufacturer focused on the development and production of infusion solutions. The company's product portfolio includes a comprehensive range of intravenous (IV) fluids, from basic solutions to advanced nutrient infusions containing essential components such as amino acids, lipids, proteins, vitamins, and minerals. A key area of innovation is the development of high-value-added products, including multi-chambered infusion solutions. The company operates world-class manufacturing facilities and maintains dedicated research and development centers to support its commitment to producing high-quality medical fluids for patient treatment.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 98% confidence The document is a regulatory announcement from JW Life Science regarding the determination of a record date for cash/in-kind dividends. It specifies the record date (2026-04-01) and the purpose (confirming shareholders for dividends). While it relates to dividends, it is specifically a notice of the record date for dividend eligibility rather than the announcement of the dividend amount itself. Given the nature of the filing as a regulatory disclosure regarding shareholder rights and dividend procedures, it falls under the general regulatory filing category.
2026-02-10 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from JW Life Science regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the dividend record date, and the date of the upcoming general meeting of shareholders to approve the dividend. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2026-02-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (JW Life Science) announcing a significant change in financial results (30% or more change in revenue or profit structure). This is a standard preliminary earnings announcement required by the Korea Exchange (KRX) for listed companies. It provides key financial highlights (revenue, operating profit, net income) for the fiscal year 2025 compared to 2024. Since it is an initial announcement of financial results rather than a full annual report or a transcript, it falls under the Earnings Release category. FY 2025
2026-02-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. It details the acquisition of shares by FIL Limited and its special related parties in JW Life Science Corporation. This type of filing is a standard regulatory requirement for entities crossing significant ownership thresholds (5% rule), which falls under the 'Major Shareholding Notification' category.
2026-01-02 Korean
기타경영사항(자율공시) (배당기준일 변경 안내)
Notice of Dividend Amount Classification · 95% confidence The document is a regulatory filing from JW Life Science regarding a change in the dividend record date policy following an amendment to the company's articles of incorporation. It informs shareholders that the dividend record date will no longer be fixed at December 31st but will be determined by the Board of Directors. Since this is a general regulatory announcement regarding corporate policy and dividend procedures rather than a specific dividend payment announcement (which would include amounts and dates) or a financial report, it falls under the general regulatory filing category.
2025-12-16 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement from JW Life Science regarding the setting of a record date for the upcoming 32nd Annual General Meeting. It is not the AGM presentation itself, nor a proxy statement, but a standard regulatory notice regarding shareholder record dates, which falls under the general regulatory filing category as it does not fit into specific categories like dividend announcements or voting results.
2025-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.